Shaanxi Micot shares nearly double in Hong Kong trading debut
Shares of drugmaker Shaanxi Micot Pharmaceutical Technology Co. Ltd. (2335.HK) jumped in their Hong Kong trading debut on Wednesday, after the company raised HK$989 million ($126 million) by selling about…
Seer Tech posts modest gain in Hong Kong trading debut
Shares of robot control systems provider Shanghai Seer Intelligent Technology Co. Ltd. (6106.HK) opened flat in their Hong Kong trading debut on Wednesday, then edged higher during the morning to…
Momenta IPO cleared by Hong Kong Stock Exchange, CSRC
Autonomous driving technology company Momenta Global Ltd. has passed its listing hearing with the Hong Kong Stock Exchange, around the same time its IPO was also approved by China’s securities…
Trunk Technology drives ahead in search of profits
The autonomous commercial vehicle technology maker plans to top up with a Hong Kong IPO under a rule allowing ‘specialist technology companies’ to list even if they are losing money…
Laifual seeks $147 million in Hong Kong IPO
Robotic precision transmission component maker Zhejiang Laifual Drive Co. Ltd. (3952.HK) began taking orders on Monday for its Hong Kong IPO, offering 13.44 million shares for between HK$77 and HK$85.50…
Xiaohongshu to file confidentially for Hong Kong IPO this month
Lifestyle platform Xiaohongshu, also known as RedNote, is preparing to confidentially file for a Hong Kong listing by the end of this month, with an aim to completing the IPO…
Fengyi IPO tests AI’s ability to fix China’s unmanned retail problem
The company is part of a second generation of unmanned retailers, as its Hong Kong IPO tests investor appetite for a cabinet network offering help-yourself snacks and drinks Key Takeaways…
Recent Articles
RELATED ARTICLES
-
Jacobio Pharma poised to turn a profit from precision cancer drugs
- Hong Kong to welcome world-leading siRNA company as Ribo launches its IPO
- Rethinking bigger Is better: China’s long march toward higher-capacity energy storage cells
- PV cell maker Yingfa Ruineng chases IPO, charged up by National Green Fund backing
- Eye drug maker VivaVision feels the strain in IPO funding dash
